# Treatment Of Radiation Retinopathy Trial

> **NCT00811200** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Leiden University Medical Center** · enrollment: 220 (estimated)

## Conditions studied

- Uveal Melanoma

## Interventions

- **DRUG:** ranibizumab
- **DRUG:** triamcinolone acetonide
- **OTHER:** sham

## Key facts

- **NCT ID:** NCT00811200
- **Lead sponsor:** Leiden University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-09
- **Primary completion:** 2012-01
- **Final completion:** —
- **Target enrollment:** 220 (ESTIMATED)
- **Last updated:** 2009-07-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00811200

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00811200, "Treatment Of Radiation Retinopathy Trial". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00811200. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*